Drug Repurposing Advantages And Strategies
By Shawn Watson, Head of Research and Development, Pharmaceutics International (Pii)
What is Drug Repurposing?
Drug repurposing became a topic of conversation this past year when existing therapeutics like the anti-malaria drug chloroquine/hydroxychloroquine and remdesivir, initially developed to treat hepatitis C were both repurposed to treat SARS-CoV-2. In fact, more than 150 drugs that are presently being used or evaluated to treat coronavirus are indeed repositioned.1
Drug repurposing is the process of identifying new therapeutic use(s) for old/existing/available drugs. It is an effective strategy in discovering or developing drug molecules with new pharmacological/therapeutic indications.
The market for repurposed drugs was valued at $24.4 billion in 20152 and is expected to reach $35 billion by 20273. Additionally, the market generates around 25% of the annual revenue for the pharmaceutical industry.2
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.